Bonesupport Holding AB - Asset Resilience Ratio
Bonesupport Holding AB (BONEX) has an Asset Resilience Ratio of 37.71% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Bonesupport Holding AB (BONEX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2016–2024)
This chart shows how Bonesupport Holding AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Bonesupport Holding AB asset portfolio.
Liquid Assets Composition Over Time
This chart breaks down Bonesupport Holding AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read BONEX total debt and obligations for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr379.02 Million | 37.71% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr379.02 Million | 37.71% |
Asset Resilience Insights
- Very High Liquidity: Bonesupport Holding AB maintains exceptional liquid asset reserves at 37.71% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Bonesupport Holding AB Industry Peers by Asset Resilience Ratio
Compare Bonesupport Holding AB's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
HOYA CORP. ADR/ 1 O.N.
F:HYB0 |
Medical Instruments & Supplies | 0.37% |
|
Andon Health Co Ltd
SHE:002432 |
Medical Instruments & Supplies | 18.11% |
|
Autek China Inc
SHE:300595 |
Medical Instruments & Supplies | 21.20% |
|
QITIAN Technology Group Co Ltd
SHE:300061 |
Medical Instruments & Supplies | 0.00% |
|
Vizionfocus Inc.
TW:4771 |
Medical Instruments & Supplies | 3.24% |
|
Amplitude Surgical SAS
PA:AMPLI |
Medical Instruments & Supplies | 0.71% |
|
Suzhou Iron Technology Co. Ltd. A
SHG:688329 |
Medical Instruments & Supplies | 0.36% |
|
DIO Corporation
KQ:039840 |
Medical Instruments & Supplies | 8.52% |
Annual Asset Resilience Ratio for Bonesupport Holding AB (2016–2024)
The table below shows the annual Asset Resilience Ratio data for Bonesupport Holding AB.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 25.80% | Skr227.00 Million ≈ $24.43 Million |
Skr879.69 Million ≈ $94.67 Million |
+1.51pp |
| 2023-12-31 | 24.30% | Skr167.35 Million ≈ $18.01 Million |
Skr688.82 Million ≈ $74.13 Million |
-29.84pp |
| 2022-12-31 | 54.13% | Skr201.28 Million ≈ $21.66 Million |
Skr371.82 Million ≈ $40.01 Million |
-5.90pp |
| 2021-12-31 | 60.03% | Skr206.46 Million ≈ $22.22 Million |
Skr343.92 Million ≈ $37.01 Million |
-16.00pp |
| 2020-12-31 | 76.04% | Skr353.74 Million ≈ $38.07 Million |
Skr465.22 Million ≈ $50.06 Million |
+29.14pp |
| 2019-12-31 | 46.89% | Skr92.06 Million ≈ $9.91 Million |
Skr196.33 Million ≈ $21.13 Million |
-33.28pp |
| 2018-12-31 | 80.17% | Skr261.47 Million ≈ $28.14 Million |
Skr326.14 Million ≈ $35.10 Million |
-9.22pp |
| 2017-12-31 | 89.39% | Skr533.37 Million ≈ $57.40 Million |
Skr596.68 Million ≈ $64.21 Million |
+14.44pp |
| 2016-12-31 | 74.94% | Skr141.50 Million ≈ $15.23 Million |
Skr188.81 Million ≈ $20.32 Million |
-- |
About Bonesupport Holding AB
Bonesupport Holding AB (publ), an orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally. The company provides CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin duri… Read more